Connected tech company Withings announced the launch of U-Scan, a biomarker assessment platform that can be placed inside a toilet bowl to monitor an individual's health using urine analysis. U-Scan ...

Finnish brand Withings is moving beyond wearables and smart scales. At CES 2023, the company is expanding into the at-home urine analysis segment — and the lineup looks quite impressive. Now, the ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Nobody likes peeing in a cup. But when it ...

Our urine reveals our well-being and how we treat our body; a researcher at Aarhus University develops effective method for analyzing urine samples, using contrast agent as a cost-effective adjuvant; ...

You wait for years for a urine analysis company, then all of them hit their flow all at once. One of the notable trends at CES in Las Vegas this year was that the quantified-self movement is going ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools. For problems in the genitourinary (GU) tract (which includes the kidneys, ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Don’t flush! Your pee could ...

And while diagnostic techniques such as blood tests, saliva analysis and eye scans all show promise, doctors still tend to rely on patients' self-reported symptoms, which are subjective. Seeking a ...

The URYXXON® 500 is an automatic reader for URYXXON® Stick 10 urine test strips. With a capacity of 400 strips per hour, it is ideal for use in hospitals and practices. The “easy-to-use-features” ...

Withings has a new streaming platform. No, not that kind of streaming. The health tech company announced U-Scan at CES 2023 on Tuesday. It's a smart device that analyses your pee from the comfort of ...

In this paper, the utility of urine-circulating microRNAs (miRNAs) as the potential biomarker of prostate cancer (PCa), the second most prevalent male cancer worldwide, was evaluated. Over 100 miRNAs ...